Stage 1 bladder cancer treatment: what to know

Stage 1 bladder cancer is generally non-muscle-invasive: the tumour has moved beyond the surface lining but has not reached the bladder muscle. The grade, number and size of tumours, previous findings, and the quality of the tissue sample all influence the plan.

A cystoscopy lets the urology team inspect the bladder. Tissue removed during the procedure is examined to confirm depth and grade. These details matter because a superficial tumour and a higher-risk tumour may need different monitoring or bladder-directed treatment.

Treatment commonly begins with a procedure through the urinary passage to remove or sample the tumour. Depending on the pathology and recurrence risk, medicine placed directly into the bladder may be recommended. Intravesical BCG therapy is one bladder-directed option; other cases need a different approach.

Ask how often cystoscopy is needed and how results will change the next step. Selected patients may discuss chemotherapy or immunotherapy, while bladder removal surgery is reserved for particular situations rather than assumed from the stage label alone.

After a procedure, seek urgent help for inability to pass urine, heavy or persistent bleeding, fever with chills, severe pain, or feeling faint. During follow-up, report recurrent blood in the urine, worsening difficulty passing urine, or new pain without waiting for the next planned visit.

Ask: What are the tumour grade and depth? Was the muscle present in the sample? Was the tumour completely removed? Would intravesical BCG therapy or another bladder treatment help? What is my cystoscopy schedule?